Royalty War

New York University has filed a lawsuit against Pfizer in an effort to collect royalty payments it says the pharma firm owes it for a lung cancer drug and diagnostic kit, according to PharmaLive.

NYU says Pfizer owes royalties on a drug called Xalkori, a receptor tyrosine kinase inhibitor that FDA cleared two years ago to treat non-small cell lung cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.